Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cryptococcal meningitis.

Tihana Bicanic1, Thomas S Harrison

  • 1Division of Infectious Diseases, Department of Cellular and Molecular Medicine, St. George's Hospital Medical School, London, UK.

British Medical Bulletin
|April 20, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Variable ectopic heterochromatin islands provide an alternative route to antifungal heteroresistance in <i>Cryptococcus neoformans</i>.

bioRxiv : the preprint server for biology·2026
Same author

Ophthalmic features of HIV associated cryptococcal meningitis in Malawian Adults: an observational study.

Wellcome open research·2026
Same author

The application of treatment response biomarkers in clinical trials for cryptococcosis, invasive aspergillosis and candidiasis.

Philosophical transactions of the Royal Society of London. Series B, Biological sciences·2026
Same author

Clinical Characteristics, Management and Outcomes of Nonintensive Care Unit Candidemia: Subanalysis of the ECMM <i>Candida</i> III Multinational European Observational Cohort Study.

Open forum infectious diseases·2026
Same author

Fluconazole plus flucytosine versus fluconazole alone for adults with HIV-associated cryptococcal antigenaemia identified through screening: a multi-centre phase III randomised-controlled trial.

Trials·2026
Same author

Inpatient initiation of tuberculosis preventive therapy with 1 month of isoniazid and rifapentine for adults with advanced HIV disease and cryptococcal meningitis (IMPROVE): a non-inferiority, randomised controlled trial.

The lancet. HIV·2026
Same journal

Human health in relation to visible, functional, and accessible green space: a systematic review and narrative synthesis of the 3 + 30 + 300 guideline.

British medical bulletin·2026
Same journal

Muscle herniae in exercise-induced leg pain: diagnostic pitfalls and the 'repair paradox'.

British medical bulletin·2026
Same journal

Scaffolds and platelet concentrates in bone regenerative medicine: applications, mechanisms, and future approaches.

British medical bulletin·2026
Same journal

Back squat and deadlift fatiguing protocols elicit distinct countermovement jump profiles: phase-specific predictors and soreness responses.

British medical bulletin·2026
Same journal

Enhancing bone healing through osteogenic medium components: biological roles, mechanisms, and clinical applications.

British medical bulletin·2026
Same journal

Moral injury in healthcare workers: causes & interventions.

British medical bulletin·2026
See all related articles

Cryptococcal meningitis in AIDS patients has high mortality due to limited antifungal drugs and increased intracranial pressure. Improved treatments and antiretroviral therapy are crucial for better outcomes in these opportunistic infections.

Area of Science:

  • Infectious Diseases
  • Neurology
  • Immunology

Background:

  • Cryptococcal meningitis is a significant opportunistic infection in individuals with Acquired Immunodeficiency Syndrome (AIDS).
  • High mortality rates persist despite current treatments, particularly in regions with a high prevalence of HIV/AIDS.
  • Raised intracranial pressure is a major complication exacerbating mortality in HIV-associated cryptococcal meningitis.

Purpose of the Study:

  • To review the current understanding of cryptococcal meningitis in HIV-infected individuals.
  • To discuss the challenges and limitations of existing therapeutic strategies.
  • To highlight areas for future research and treatment improvement.

Main Methods:

  • Literature review of cryptococcal meningitis in immunocompromised patients.

Related Experiment Videos

  • Analysis of current treatment guidelines and their efficacy.
  • Discussion of complications and management strategies.

    • Main Results:

    • Mortality from HIV-associated cryptococcal meningitis remains high (10-30%) due to drug limitations and intracranial pressure.
    • Optimal therapy involves amphotericin B and flucytosine, followed by fluconazole, with supportive measures like saline loading and CSF drainage.
    • Antiretroviral therapy expansion offers hope for long-term prognosis if the acute phase is managed successfully.

    Conclusions:

    • There is a critical need for more effective antifungal drug regimens.
    • Improved management of raised intracranial pressure is essential for reducing mortality.
    • Advancements in antiretroviral programs, coupled with optimized meningitis treatment, can transform patient outcomes.